Kerendia^®

(Finerenone)⁴ Bayer

• Finerenone is a nonsteroidal mineralocorticoid receptor (MR) antagonist

Composition:

• Available as 10mg and 20mg oral tablets

Indications:

Newly indicated for delaying progressive decline of kidney function in adults with chronic kidney disease associated with type 2 diabetes (with albuminuria), in addition to standard of care

Reference:

4. Kerendia^® (finerenone). Prescribing Information.